To additionally validate MDGA1 expression as a biomarker for other inflammatory diseases, we analyzed a large publicly available single-cell dataset of PBMCs from multiple sclerosis (MS) patients [41]. This evidence concerns the gene MDGA1 and myeloid sarcoma.